CAR-T Cell Therapy

Mayo Clinic researchers are collaborating to develop CAR-T cell therapy for solid tumors in thyroid cancer.

After Sylvester Pinckney's lymphoma returned, chimeric antigen receptor-T cell therapy at Mayo Clinic put his cancer back in remission.

After receiving CAR-T cell therapy at Mayo Clinic, Welsh-born John Cadwallader achieved remission and found new hope. He now receives care in the U.K. and is monitored by Mayo in the U.S. and London.

Learn about CAR-T cell therapy and research at Mayo Clinic to reduce its side effects and expand its use beyond blood cancers.

Dr. Mohamed Kharfan Dabaja discusses who is eligible for CAR-T cell therapy, the treatment process and its potential side effects.

After receiving CAR-T cell therapy for chronic lymphocytic leukemia through a clinical trial at Mayo Clinic, Jon Stahlecker is cancer free and feeling good.

The story of Brooke Michael's journey to successful CAR-T cell therapy treatment after being diagnosed with primary B-cell lymphoma at 17.

Cancer experts have been exploring and improving multiple myeloma treatments that can extend periods of remission and enhance quality of life.

Learn about CAR-T cell therapy, a personalized treatment giving hope to patients diagnosed with various lymphomas.

If you or someone you love has been diagnosed with leukemia, learning more about the disease can help you cope. Start with this quick overview.